Protective effects of Tat-DJ-1 protein against streptozotocin-induced diabetes in a mice model |
Yeo, Hyeon Ji
(Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Yeo, Eun Ji (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) Shin, Min Jea (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) Choi, Yeon Joo (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) Lee, Chi Hern (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) Kwon, Hyeok Yil (Department of Physiology, College of Medicine, Hallym University) Kim, Dae Won (Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University) Eum, Won Sik (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) Choi, Soo Young (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) |
1 | Shi Y, Wan X, Shao N, Ye R, Zhang N and Zhang Y (2016) Protective and anti-angiopathy effects of ginsenoside Re against diabetes mellitus via the activation of p38MAPK, ERK1/2 and JNK signaling. Mol Med Rep 14, 4849-4856 DOI |
2 | Zhang Y, Mei H, Shan W et al (2016) Lentinan protects pancreatic cells from STZ-induced damage. J Cell Mol Med 20, 1803-1812 DOI |
3 | Sakai N, Wada T, Furuichi K et al (2005) Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis 45, 54-65 DOI |
4 | Weih F, Carrasco D, Durham SK et al (1995) Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the /Rel family. Cell 80, 331-340 DOI |
5 | Mollah ZH, Pai S, Moore C et al (2008) Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytes. J Immunol 180, 3166-3175 DOI |
6 | Lundh M, Scully SS, Mandrup-Poulsen T and Wagner BK (2013) Small-molecule inhibition of inflammatory beta cell death. Diabetes Obes Metab 15, 176-184 DOI |
7 | Donath MY and Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11, 98-107 DOI |
8 | Rabinovitch A and Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55, 1139-1149 DOI |
9 | Kellogg AP, Cheng HT and Pop-Busui R (2008) Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy. Curr Drug Targets 9, 68-76 DOI |
10 | Bujalska-Zadrozny M, de Corde A and Pawlik K (2015) Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinosids activity in streptozotocininduced neuropathy. Pharmacol Rep 67, 209-216 DOI |
11 | An SY, Youn GS, Kim HJ, Choi SY and Park J (2017) Celastrol suppresses expression of adhesion molecules and chemokines by inhibiting JNK-STAT1/ activation in poly(I:C)-stimulated astrocytes. BMB Rep 50, 25-30 DOI |
12 | Bujalska M, Tatarkiewicz J, de Corde A and Gumulka SW (2008) Effects of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats. Pharmacol 81, 151-157 DOI |
13 | Ahn EH, Kim DW, Shin MJ et al (2016) Tat-ATOX1 inhibits streptozotocin-induced cell death in pancreatic RINm5F cells and attenuates diabetes in a mouse model. Int J Mol Med 38, 217-224 DOI |
14 | Yang SJ, Kim J, Lee SE, Ahn JY, Choi SY and Cho SW (2017) Anti-inflammatory and anti-oxidative effects of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on -amyloid-induced microglial activation. BMB Rep 50, 634-639 DOI |
15 | Rui L (2014) Energy metabolism in the liver. Compr Physiol 4, 177-197 |
16 | Lukic ML, Pejnovic N and Lukic A (2014) New insight into early events in type 1 diabetes: role for islet stem cell exosomes. Diabetes 63, 835-837 DOI |
17 | Daneman D (2006) Type 1 diabetes. Lancet 367, 847-858 DOI |
18 | Welters A and Lammert E (2014) Diabetes Mellitus. In: Lammert E, Zeeb M (eds) Metabolism of human diseases: organ physiology and pathophysiology. Springer, Vienna, 163-173 |
19 | Fiorentino TV, Prioletta A, Zuo P and Folli F (2013) Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 19, 5695-5703 DOI |
20 | Esposito K, Marfella R and Giugliano D (2003) Stress hyperglycemia, inflammation, and cardiovascular events. Diabetes Care 26, 1650-1651 |
21 | Hayashi K, Kojima R and Ito M (2006) Strain differences in the diabetogenic activity of streptozotocin in mice. Biol Pharm Bull 29, 1110-1119 DOI |
22 | Ariga H, Takahashi-Niki K, Kato I, Maita H, Niki T and Iguchi-Ariga SM (2013) Neuroprotective function of DJ-1 in Parkinson's disease. Oxidative Med Cell Longev 2013, 683920 |
23 | Mikio I, Yoichi K, Akiko N, Koji H and Atsuhiko N (2001) Characterization of low dose streptozotocin-induced progressive diabetes in mice. Environ Toxicol Pharmacol 9, 71-78 DOI |
24 | Nagakubo D, Taira T, Kitaura H et al (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231, 509-513 DOI |
25 | Wilson MA (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal 15, 111-122 DOI |
26 | Bonifati V, Rizzu P, van Baren MJ et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259 DOI |
27 | Jain D, Jain R, Eberhard D et al (2012) Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes. J Mol Cell Biol 4, 221-230 DOI |
28 | Yu HH, Xu Q, Chen HP et al (2013) Stable overexpression of DJ-1 protects H9c2 cells against oxidative stress under a hypoxia condition. Cell Biochem Funct 31, 643-651 DOI |
29 | Inden M, Taira T, Kitamura Y et al (2006) PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol Dis 24, 144-158 DOI |
30 | Kim RH, Smith PD, Aleyashin H et al (2005) Hypersensitive of DJ-1-deficient mice to 1-methtyl-4-phenyl- 1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A 102, 5215-5220 DOI |
31 | Wadia JS and Dowdy SF (2002) Protein transduction technology. Curr Opin Biotechnol 13, 52-56 DOI |
32 | Jo HS, Eum WS, Park EY et al (2017) Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease. BMB Rep 50, 460-465 DOI |
33 | van den Berg A and Dowdy SF (2011) Protein transduction domain delivery of therapeutic macromolecules. Curr Opin Biotechnol 22, 888-893 DOI |
34 | Kubo E, Fatma N, Akagi Y, Beier DR, Singh SP and Singh DP (2008) TAT-mediated PRDX6 protein transduction protects against eye lens epithelial cell death and delays lens opacity. Am J Physiol Cell Physiol 294, C842-C855 DOI |
35 | Embury J, Klein D, Pileggi A et al (2001) Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes 50, 1706-1713 DOI |
36 | Jo HS, Yeo HJ, Cha JH et al (2016) Transduced Tat-DJ-1 protein inhibits cytokine-induced pancreatic RINm5F cell death. BMB Rep 49, 297-302 DOI |
37 | Jo HS, Cha HJ, Kim SJ et al (2016) Tat-DJ-1 inhibits oxidative stress-mediated RINm5F cell death through suppression of and MAPK activation. Med Chem Res 25, 2589-2598 DOI |
38 | Jo HS, Yeo EJ, Shin MJ et al (2017) Tat-DJ-1 enhances cell survival by inhibition of oxidative stress, and MAPK activation in HepG2 cells. Biotechnol Lett 39, 511-521 DOI |
39 | Kim MJ, Kim DW, Lee BY et al (2013) Transduced Tat-glyoxalase protein attenuates streptozotocin-induced diabetes in a mouse model. Biochem Biophys Res Commun 430, 294-300 DOI |
40 | Szkudelski T (2001) The mechanisms of alloxan and streptozotocin action in -cells of rat pancreas. Physiol Res 50, 536-546 |
41 | Jain D, Weber G, Eberhard D et al (2015) DJ-1 protects pancreatic beta cells from cytokine- and streptozotocinmediated cell death. PLoS One 10, e0138535 DOI |
42 | Singh R, Bhardwaj P and Sharma P (2013) Antioxidant and toxicological evaluation of Cassia sopherain streptozotocin-induced diabetic Wister rats. Pharmacognosy Res 5, 225-232 DOI |
43 | Robertson RP (2009) Beta-cell deterioration during diabetes: what's in the gun? Trends Endocrinol Metab 20, 388-393 DOI |
44 | Mota M, Banini BA, Cazanave SC and Sanyal AJ (2016) Molecular mechanism of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism 65, 1049-1061 DOI |
45 | Navarro C, Montilla P, Martin A, Jimenez J and Utrilla P (1993) Free radicals scavenger and antihepatotoxic activity of Rosmarinus. Planta Med 59, 312-314 DOI |
46 | Ren H, Fu K, Mu C, Li B, Wang D and Wang G (2010) DJ-1, a cancer and Parkinson's disease associated protein, regulates autophagy through JNK pathway in cancer cells. Cancer Lett 297, 101-108 DOI |
47 | Gu L, Cui T, Fan C et al (2009) Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress. Biochem Biophys Res Commun 383, 469-474 DOI |
48 | Im JY, Lee KW, Junn E and Mouradian MM (2010) DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex. Neurosci Res 67, 203-208 DOI |
49 | Sakai N, Wada T, Furuichi K et al (2002) p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant 17, 998-1004 DOI |
50 | Jaramillo-Gomez J, Nino A, Arboleda H and Arboleda G (2015) Overexpression of DJ-1 protects against C2-ceramide-induced neuronal death through activation of the PI3K/AKT pathway and inhibition of autophagy. Neurosci Lett 603, 71-76 DOI |